Jay Patel
Pain Medicine · Coppell, TXNPI 1477058535
Payments from drug & device makers
Across 124 payments — averaging $84.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$8K
- Boston Scientific$471
- Collegium Pharmaceutical, Inc.$357
- Nevro Corp.$300
- Abbott$234
- Amgen$230
- plus $1K from 17 others
What the payments were for
- Grants$3,75036%
- Travel & lodging$2,68926%
- Food & beverage$3,94937%
- Education$1451%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 38 | $7,715 |
| Boston Scientific | 6 | $471 |
| Collegium Pharmaceutical, Inc. | 19 | $357 |
| Nevro Corp. | 7 | $300 |
| Abbott | 3 | $234 |
| Amgen | 1 | $230 |
| Pfizer | 14 | $218 |
| Stryker | 1 | $169 |
| Scilex Pharmaceuticals Inc. | 6 | $136 |
| AstraZeneca | 1 | $103 |
| Curonix LLC | 1 | $98 |
| Azurity Pharmaceuticals, Inc. | 4 | $71 |
| Vertex | 3 | $64 |
| AbbVie | 3 | $59 |
| Valinor Pharma, LLC | 3 | $59 |
| Otsuka America Pharmaceutical, Inc. | 3 | $48 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $47 |
| Novo Nordisk | 2 | $44 |
| Exact Sciences | 2 | $32 |
| Xeris Pharmaceuticals, Inc. | 1 | $22 |
| Lilly USA, LLC | 1 | $19 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $19 |
| Si-bone, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SYNCHROMEDII$3,750
- INTELLIS ADAPTIVESTIM$1,498
- KYPHON EXPRESS II KYPHOPAK TRAY$1,355
- mild Device Kit$169
- GENERAL - THERAPIES$163
- ENSITE$145
- WaveWriter Alpha Prime 16$137
- Omnia$127
How this compares
$10,533 in reported general payments places this provider in the 75th percentile of 583 pain medicine providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 2,314 | $88,041 |
| Buprenorphine | 163 | $45,651 |
| BelbucaBuprenorphine Hcl | 41 | $24,439 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 443 | $14,374 |
| Xtampza ErOxycodone Myristate | 16 | $12,120 |
| Fentanyl | 73 | $9,911 |
| Pregabalin | 364 | $9,087 |
| Emgality PenGalcanezumab-Gnlm | 13 | $9,078 |
| LinzessLinaclotide | 15 | $8,222 |
| BelsomraSuvorexant | 16 | $7,056 |
| Lidocaine | 78 | $6,123 |
| Gabapentin | 428 | $5,835 |
| Oxycodone Hcl | 317 | $5,759 |
| MovantikNaloxegol Oxalate | 14 | $5,645 |
| Tizanidine Hcl | 369 | $5,377 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Belbuca, Xtampza Er | $357 | $36,55957 claims |
| AbbVieLinzess | $59 | $8,22215 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 583 pain medicine providers in Texas.
Other pain medicine in Coppell
- Aaron CalodneyTyler$3M
- Mitchell EngleHouston$1.5M
- Melissa MurphyGrapevine$711K
- Shiraz YazdaniLubbock$632K
- Muhammad ZulqarnainDallas$556K
- Daniel PakHouston$460K
- Marvin ChangSugar Land$306K
- David LeimanHouston$281K
- Candice BurnetteSugar Land$265K
- Ellen LinSan Antonio$251K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.